Advances in Malignant Hematology by Hussain I. SabaAdvances in Malignant Hematology by Hussain I. Saba

Advances in Malignant Hematology

EditorHussain I. Saba, Ghulam Mufti

Hardcover | May 2, 2011

Pricing and Purchase Info

$170.84 online 
$211.95 list price save 19%
Earn 854 plum® points

Prices and offers may vary in store


Ships within 1-3 weeks

Ships free on orders over $25

Not available in stores


This comprehensive book captures and compiles new and current information on hematologic malignancies. New knowledge of cellular disease processes, molecular pathology, and cytogenetic, epigenetic and genomic changes has influenced the current outlook toward haematological malignancies. This recent and ongoing expansion of knowledge on malignant hematology has not previously been utilized to its full capacity due to its diffuse distribution scattered over the internet and research publications. This book is written by experts from the American and European continent, sharing their current thoughts and knowledge on the pathobiology of malignant haematological diseases of the blood, as well as current treatment strategies and future developments in the area of these haematological diseases.
Hussain I. Saba, Department of Medicine, University of South Florida College of Medicine; James A. Haley Veterans Hospital; H. Lee Moffitt Cancer Center and Research Institute; , Tampa, FL, USA Ghulam Mufti, Department of Haematological Medicine, Guy’s and St. Thomas’s School of Medicine, King’s College Hospital, London, UK
Title:Advances in Malignant HematologyFormat:HardcoverDimensions:440 pages, 9.6 × 7.5 × 1.1 inPublished:May 2, 2011Publisher:WileyLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1405196262

ISBN - 13:9781405196260

Look for similar items by category:


Table of Contents

Part 1: Hematopoiesis.

1 Normal and Malignant Hematopoiesis (Bijal D. Shah and Kenneth S. Zuckerman).

2 The Leukemic Genome (Jonathan C. Strefford and Nicholas CP Cross).

Part 2: Myeloid Malignancies.

3 Myeloproliferative Neoplasms (Ruben A. Mesa and Ayalew Tefferi).

4 CML: Molecular Biology of BCR-Able (Javier I. Pinilla-Ibarz, Eric Padron and Lori Hazlehurst).

5 Standard Management of Patients with CML (Chronic Myeloid Leukemia) (Elias Jabbour, Jorge Cortes and Hagop Kantarjian).

6 The Molecular Biology of Acute Myeloid Leukemia (Jerald Radich).

7 Acute Myeloid Leukemia (Martin S. Tallman, Ritesh Parajuli and Jessica K. Altman).

8 Acute promyelocytic leukemia (APL) (Sylvain Thépot, Lionel Ades and Pierre Fenaux).

9 A Pluralistic approach to the study of myelodysplastic syndromes: Evolving pathology of the Seed via the Soil (Naomi Galili, Raymond Cruz, Jamie Stratton, Jessica Clima, Ghulam Sajjad Khan and Azra Raza).

10 Myelodysplastic Syndrome: A Review of Current Care (Kenneth H. Shain, Alan F. List and Rami S. Komrokji).

11 Supportive Care in Myelodysplastic Syndrome (MDS) (Hussain I. Saba, Arshia A. Dangol and Donald C. Doll).

Part 3: Lymphoid Malignancies.

12 Molecular Biology of Chronic Lymphoproliferative Disorders (Monique A. Hartley and Lubomir Sokol).

13 Chronic Lymphocytic Leukemia (Terry Hamblin and Angela Hamblin).

14 Acute Lymphoblastic Leukemia (Susan O'Brien, Stefan Faderl,  Deborah Thomas  and Hagop M. Kantarjian).

15 Large Granular Lymphocyte Leukemia (Xin Liu and Thomas P. Loughran, Jr.).

16 Hairy Cell Leukemia (Kevin T. Kim, Darren S. Sigal and Alan Saven).

17 Molecular Basis of B-cell Lymphomas (Elizabeth M. Sagatys, Eduardo M. Sotomayor and Jianguo Tao).

18 Non-Hodgkin’s Lymphomas (Peter McLaughlin and Nathan Fowler).

19 Hodgkin Lymphoma (Michael Crump).

Part 4: Plasma Cell Disorders.

20 Multiple Myeloma:  Molecular Biology, Diagnosis and Treatment (S. Vincent Rajkumar and Shaji Kumar).

21 Waldenström’s Macroglobulinemia (Robert A. Kyle and Suzanne Hayman).

22 Primary Systemic (AL) Amyloidosis (Efstathios Kastritis and Meletios Athanasios Dimopoulos).

Part 5: Bone Marrow Transplantation and Quality of Life.

23 Advances in allogeneic hematopoietic cell transplantation: progress in transplantation technology and disease-specific outcomes (Joseph Pidala and Claudio Anasetti).

24 Quality of Life after the diagnosis of Hematological Malignancies (Mohamed Sorror).